Table 2.
Relative risk of micro-nutrient deficiency
| Variable | Uni-variate analysis | Multi-variate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | |
| Male sex | 0.842 (0.478–1.485) | 0.553 | 0.718 (0.375–1.376) | 0.319 |
| Age | 0.975 (0.958–0.993) | 0.006 | 0.973 (0.949–0.998) | 0.037 |
| The path of laboratory test | ||||
| Outpatients clinic | 1.0 (Ref.) | 1.0 (Ref.) | ||
| Hospitalization patients | 2.204 (0.735–6.608) | 0.158 | 2.459 (0.715–8.461) | 0.154 |
| Type of disease | ||||
| UC | 1.0 (Ref.) | 1.0 (Ref.) | ||
| CD | 3.810 (1.721–8.430) | 0.001 | 2.492 (1.012–6.136) | 0.047 |
| Intestinal BD | 2.778 (0.734–10.513) | 0.132 | 1.356 (0.284–6.479) | 0.703 |
| Medications | ||||
| 5-ASA | 0.381 (0.214–0.679) | 0.001 | 0.548 (0.281–1.068) | 0.077 |
| Steroids | 0.502 (0.132–1.914) | 0.313 | ||
| Azathioprine | 1.784 (0.983–3.238) | 0.057 | ||
| Anti-TNF | 1.584 (0.900–2.788) | 0.111 | ||
| Methotrexate | 0.746 (0.340–1.637) | 0.465 | ||
| Othersa | 0.295 (0.063–1.383) | 0.121 | ||
| Operation | 2.041 (1.120–3.717) | 0.020 | 2.714 (1.260–5.844) | 0.011 |
| Underlying disease | ||||
| Hypertension | 0.515 (0.053–5.037) | 0.568 | ||
| Osteoporosis | 0.776 (0.371–1.624) | 0.501 | 1.500 (0.699–3.217) | 0.298 |
| Othersb | 1.131 (0.579–2.206) | 0.719 | 2.459 (0.715–8.461) | 0.154 |
OR, odds ratio; CI, confidence interval; UC, Ulcerative colitis; CD, Crohn’s disease; BD, Behçet’s disease; 5-ASA, 5-aminosalicylic acid; anti-TNF, anti-tumor necrosis factor
aMongersen, vedolizumab
bMDS, SLE, AR, BOOP, OA, Osteoporosis, CAOD, cancer